Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Lipoprotein(a) Level”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Large-scale testing (Phase 3)Study completedNCT00092638
What this trial is testing

An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

Who this might be right for
HypercholesterolemiaCoronary Disease
Organon and Co 450
Testing effectiveness (Phase 2)Study completedNCT00689442
What this trial is testing

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Who this might be right for
Dyslipidemia
Akros Pharma Inc. 105
Large-scale testing (Phase 3)UnknownNCT00633698
What this trial is testing

Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)

Who this might be right for
Elevated Lipoprotein(a) Levels
Charite University, Berlin, Germany 150
Not applicableLooking for participantsNCT06995183
What this trial is testing

Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Identified Through Family Screening

Who this might be right for
Lipoprotein(a)
E.S.stroes 150
Testing effectiveness (Phase 2)Study completedNCT00688558
What this trial is testing

Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Who this might be right for
Dyslipidemia
Akros Pharma Inc. 92
Not applicableLooking for participantsNCT05614219
What this trial is testing

Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.

Who this might be right for
Familial Hypercholesterolemia
Odense University Hospital 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT07477704
What this trial is testing

See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Regeneron Pharmaceuticals 420
Early research (Phase 1)Not Yet RecruitingNCT07074236
What this trial is testing

Pharmacokinetics and Pharmacodynamics Study

Who this might be right for
Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C
Qilu Pharmaceutical Co., Ltd. 48
Not applicableActive Not RecruitingNCT06304415
What this trial is testing

Elevated Lipoprotein(a) in Hospital Staff

Who this might be right for
HypercholesterolemiaLipoprotein Types--Lp System Lp(A) HyperlipoproteinemiaCardiovascular Diseases
Changi General Hospital 2,800
Testing effectiveness (Phase 2)Study completedNCT01375777
What this trial is testing

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

Who this might be right for
Hyperlipidemia
Amgen 411
Large-scale testing (Phase 3)Study completedNCT00092625
What this trial is testing

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

Who this might be right for
HypercholesterolemiaCoronary Disease
Organon and Co 442
Large-scale testing (Phase 3)Ended earlyNCT00239681
What this trial is testing

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

Who this might be right for
Elevated High-sensitivity C-Reactive Protein (hsCRP)
AstraZeneca 17,802
Not applicableLooking for participantsNCT06014060
What this trial is testing

24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial

Who this might be right for
Elevated Lipoprotein(a) LevelCoronary Artery DiseaseDrug-Eluting Stent+1 more
China National Center for Cardiovascular Diseases 3,300
Large-scale testing (Phase 3)Study completedNCT02116517
What this trial is testing

Effects of Green Tea Extract on Obese Women With High Level of LDL

Who this might be right for
ObeseHyperlipidemia
National Yang Ming Chiao Tung University 73
Very early researchStudy completedNCT05178550
What this trial is testing

A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.

Who this might be right for
Healthy Volunteers
Novo Nordisk A/S 12
Large-scale testing (Phase 3)Study completedNCT00092612
What this trial is testing

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)

Who this might be right for
HypercholesterolemiaCoronary Disease
Organon and Co 372
Early research (Phase 1)Study completedNCT05787002
What this trial is testing

Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.

Who this might be right for
Dyslipidemia
AstraZeneca 16
Early research (Phase 1)Active Not RecruitingNCT07423598
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels

Who this might be right for
Healthy Participants
AstraZeneca 40
Testing effectiveness (Phase 2)Study completedNCT00697203
What this trial is testing

Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)

Who this might be right for
Dyslipidemia
Hoffmann-La Roche 292
Early research (Phase 1)Study completedNCT01487460
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients

Who this might be right for
DyslipidemiaHealthy Volunteers
Novartis Pharmaceuticals 137
Load More Results